Table 1 Demographic characteristics of the patient included for analysis
From: The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment
Characteristics | n = 89 |
|---|---|
Age (median, IQR) | 63 (51–72) |
Male (n,%) | 49 (55) |
HTN (n, %) | 25(28) |
DM (n, %) | 6(7) |
Dyslipidaemia (n,%) | 33(37) |
Smoker or Ex smoker (%) | 23 (26) |
Previous cardiac disease (n, %) | 14(16) |
BMI (mean, SD) | 27 (5.5) |
LVEF (median, IQR) | 60 (12) |
LVEF < 50% (n, %) | 17(19) |